Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
Get this in your inbox everyday by subscribing to our newsletters.
5. Pulse Biosciences pounds out $20m with IPO
Pulse Biosciences raised $20 million in an initial public offering this week after floating 5 million shares at $4 apiece, for a fully diluted valuation of $51 million.
Burlingame, Calif.-based Pulse is developing “nano-pulse electro-signaling,” in which extremely short-duration pulsed electrical fields are directed at solid tumors. It’s designed to induce a type of programmed cell death called immunogenic apoptosis, which can trigger the body’s immune response to find and kill other cells of the same type. Read more
4. EuroPCR 2016: Study casts doubt on long-term TAVR durability
Study results released this week at the annual EuroPCR conference in Paris indicated that half of transcatheter aortic valve replacements had signs of degeneration within 10 years.
The study looked at 704 patients who had a TAVR procedure between April 2002 and May 2011, following 378 of them for up to 10 years. In the 100 patients who survived for at least 5 years, there were 35 cases of valve degeneration, with a significant number showing deterioration between 5 and 7 years after TAVR implantation. The study’s authors estimated that the 8-year rate of degeneration was roughly 50%. Read more
3. FDA approves Boston Scientific’s Precision Montage MRI-safe spinal cord stimulator
Boston Scientific said it won FDA approval for its Precision Montage MRI-safe spinal cord stimulator for chronic pain and plans to launch the device tomorrow.
The Precision Montage MRI SCS is cleared for full-body, 1.5 Tesla MRI scans, the Marlborough, Mass.-based company said. It’s designed to deliver multiple waveforms so patients can tailor their therapy as their pain evolves, and uses Boston Scientific’s IlLumina 3D algorithm to create a computer model so surgeons can target the source of the pain. Read more
2. Philips inks $36m patient monitoring deal with Medical University of South Carolina Health
Royal Philips said it inked an 8-year, $36 million deal with Medical University of South Carolina Health for its patient monitoring technology and services.
The deal calls for the Dutch conglomerate to install, integrate and manage patient monitoring systems and software, plus maintenance, training and consulting services, for the South Carolina healthcare provider, using a structured monthly payment model. Read more
1. Medtronic: Infuse data delay was inadvertent
Medtronic reportedly said this week that its years-long delay in releasing adverse event data for its controversial Infuse bone-growth protein was inadvertent.
The Minneapolis Star Tribune last month reported that a 2-year Medtronic review of some 3,647 Infuse patients in 2008 turned up about 1,000 adverse events that weren’t reported to the FDA until 2013. Read more
The post MassDevice.com +5 | The top 5 medtech stories for May 19, 2016 appeared first on MassDevice.
from MassDevice http://ift.tt/1U2GRpR
Cap comentari:
Publica un comentari a l'entrada